Abstract
Disease Activity Score in 28 joints (DAS28) is commonly used to evaluate disease activity of rheumatoid arthritis (RA) and is a guide to treatment decision. The aim of this study was to evaluate the impact of lower reporting limit for C-reactive protein (CRP), with respect to intraindividual biological variability, on the calculation of DAS28 and subsequent patient classification. This study consists of 2 sections: a theoretical consideration discussing the performance of CRP in calculating DAS28 taking intraindividual biological variation and lower reporting limit for CRP into account and a cross-sectional study of RA patients applying our theoretical results. Therefore, we calculated DAS28 twice, with the actual CRP values and CRP= 9 mg/L, the latter to elucidate the positive effects of reducing the lower reporting limit of CRP from
Originalsprog | Engelsk |
---|---|
Tidsskrift | Medicine (United States) |
Vol/bind | 96 |
Udgave nummer | 1 |
ISSN | 0025-7974 |
DOI | |
Status | Udgivet - jan. 2017 |
Udgivet eksternt | Ja |